Literature DB >> 9034814

Eating attitudes and the irritable bowel syndrome.

G Sullivan1, A E Blewett, P L Jenkins, M C Allison.   

Abstract

A series of 48 new patients with irritable bowel syndrome (IBS) were asked to complete an Eating Attitudes Test. The same test was given to a series of 32 patients attending an Eating Disorder clinic, a series of 31 patients attending a gastroenterology outpatient clinic with a diagnosis of inflammatory bowel disease (IBD), and to a group of 28 'normal' controls. The results showed that there was no significant difference between the IBD group and control groups for EAT score. The EAT score for the group with eating disorders was significantly higher than for all other groups. The EAT score for the IBS group was greater than those for the IBD and control group (p = 0.05) when all four groups were compared using analysis of variance and the Least Significant Difference test.

Entities:  

Mesh:

Year:  1997        PMID: 9034814     DOI: 10.1016/s0163-8343(96)00106-5

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  4 in total

Review 1.  The eating attitudes test: twenty-five years later.

Authors:  P E Garfinkel; A Newman
Journal:  Eat Weight Disord       Date:  2001-03       Impact factor: 4.652

Review 2.  Chronic illness and disordered eating: a discussion of the literature.

Authors:  Virginia M Quick; Carol Byrd-Bredbenner; Dianne Neumark-Sztainer
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

3.  Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study.

Authors:  Ture Alander; Kurt Svärdsudd; Sven-Erik Johansson; Lars Agréus
Journal:  BMC Med       Date:  2005-05-13       Impact factor: 8.775

4.  Disorders of the brain-gut interaction and eating disorders.

Authors:  Mihaela Fadgyas Stanculete; Giuseppe Chiarioni; Dan Lucian Dumitrascu; Dinu Iuliu Dumitrascu; Stefan-Lucian Popa
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.